Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Primary Membranoproliferative Glomerulonephritis
NCT03180723Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Jul 2017
- Primary completion
- Jul 2019
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of rituximab in membranoproliferative glomerulonephritis (MPGN), sponsored by Assiut University. Status: unknown.
02
Drugs
rituximab
03
Conditions
membranoproliferative glomerulonephritis (MPGN)
Beyond the preview
Go deeper on NCT03180723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180723.